XPhyto reports excellent Rotigotine in-vitro/ex-vivo results for Parkinson’s disease treatment
Oct 18, 2022
Vancouver, Canada, and Uttenweiler, Germany (October 18, 2022) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to report...